Browsing by Author Dolton, Michael

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 13 of 13
Issue DateTitleAuthor(s)Citation
2012Fruit Juices as Perpetrators of Drug Interactions: The Role of Organic Anion-Transporting PolypeptidesDolton, Michael; McLachlan, Andrew; Roufogalis, Basil; Pharmacy; Pharmacy; PharmacyFruit Juices as Perpetrators of Drug Interactions: The Role of Organic Anion-Transporting Polypeptides, Clinical Pharmacology and Therapeutics, vol.92, 5, 2012,pp 622-630
2012Multicenter Study of Posaconazole Therapeutic Drug Monitoring: Exposure-Response and Factors Affecting ConcentrationChen, Sharon; Dolton, Michael; McLachlan, Andrew; Pont, Lisa; Ng, Kingsley; Ray, John E.; Western Clinical School: Medicine (Westmead); Pharmacy; Pharmacy; Faculty of Nursing & MidwiferyMulticenter Study of Posaconazole Therapeutic Drug Monitoring: Exposure-Response and Factors Affecting Concentration, Antimicrobial Agents and Chemotherapy, vol.56, 11, 2012,pp 5503-5510
2012Multicenter Study of Voriconazole Pharmacokinetics and Therapeutic Drug MonitoringChen, Sharon; Dolton, Michael; McLachlan, Andrew; Pont, Lisa; Ng, Kingsley; Ray, John E.; Western Clinical School: Medicine (Westmead); Pharmacy; Pharmacy; PharmacyMulticenter Study of Voriconazole Pharmacokinetics and Therapeutic Drug Monitoring, Antimicrobial Agents and Chemotherapy, vol.56, 9, 2012,pp 4793-4799
2014Optimal sampling of antipsychotic medicines: a pharmacometric approach for clinical practiceDolton, Michael; McLachlan, Andrew; Bies, Robert; Carr, Vaughan J.; Day, Richard O; Forrest, Alan; Mo, Gary; Perera, Vidya; Polasek, Thomas; Pharmacy; PharmacyOptimal sampling of antipsychotic medicines: a pharmacometric approach for clinical practice, British Journal of Clinical Pharmacology, vol.78, 4, 2014,pp 800-814
2014Optimizing azole antifungal therapy in the prophylaxis and treatment of fungal infectionsDolton, Michael; McLachlan, Andrew; Pharmacy; PharmacyOptimizing azole antifungal therapy in the prophylaxis and treatment of fungal infections, Current Opinion in Infectious Diseases, vol.27, 6, 2014,pp 493-500
2012Posaconazole exposure-response relationship: evaluating the utility of therapeutic drug monitoringDolton, Michael; McLachlan, Andrew; Marriott, Deborah; Ray, John E.; Pharmacy; PharmacyPosaconazole exposure-response relationship: evaluating the utility of therapeutic drug monitoring, Antimicrobial Agents and Chemotherapy (online), vol.56, 6, 2012,pp 2806-2813
2012Prevalence of potentially harmful drug interactions in older people in Australian aged-care facilitiesDolton, Michael; McLachlan, Andrew; Pont, Lisa; Stevens, Gerard; Pharmacy; Pharmacy; PharmacyPrevalence of potentially harmful drug interactions in older people in Australian aged-care facilities, Journal of Pharmacy Practice and Research, vol.42, 1, 2012,pp 33-36
2014Terbinafine in Combination with Other Antifungal Agents for Treatment of Resistant or Refractory Mycoses: Investigating Optimal Dosing Regimens Using a Physiologically Based Pharmacokinetic ModelDolton, Michael; McLachlan, Andrew; Pont, Lisa; Perera, Vidya; Pharmacy; Pharmacy; Faculty of Nursing & MidwiferyTerbinafine in Combination with Other Antifungal Agents for Treatment of Resistant or Refractory Mycoses: Investigating Optimal Dosing Regimens Using a Physiologically Based Pharmacokinetic Model, Antimicrobial Agents and Chemotherapy, vol.58, 1, 2014,pp 48-54
2014Terbinafine in Combination with Other Antifungal Agents for Treatment of Resistant or Refractory Mycoses: Investigating Optimal Dosing Regimens Using a Physiologically Based Pharmacokinetic ModelDolton, Michael; McLachlan, Andrew; Pont, Lisa; Perera, Vidya; Pharmacy; Pharmacy; Faculty of Nursing & MidwiferyTerbinafine in Combination with Other Antifungal Agents for Treatment of Resistant or Refractory Mycoses: Investigating Optimal Dosing Regimens Using a Physiologically Based Pharmacokinetic Model, Antimicrobial Agents and Chemotherapy, vol.58, 1, 2014,pp 48-54
2014Understanding Variability in Posaconazole Exposure Using an Integrated Population Pharmacokinetic AnalysisDolton, Michael; McLachlan, Andrew; Brüggemann, Roger J M; Burger, David; Pharmacy; PharmacyUnderstanding Variability in Posaconazole Exposure Using an Integrated Population Pharmacokinetic Analysis, Antimicrobial Agents and Chemotherapy, vol.58, 11, 2014,pp 6879-6885
2014Understanding variability with voriconazole using a population pharmacokinetic approach: implications for optimal dosingDolton, Michael; McLachlan, Andrew; Mikus, Gerd; Ray, John E.; Weiss, Johanna; Pharmacy; PharmacyUnderstanding variability with voriconazole using a population pharmacokinetic approach: implications for optimal dosing, Journal of Antimicrobial Chemotherapy, vol.69, 6, 2014,pp 1633-1641
2010Vancomycin pharmacokinetics in patients with severe burn injuriesCheong, Elaine; Dolton, Michael; Gottlieb, Thomas; Maitz, Peter; McLachlan, Andrew; Xu, Hongmei; Buono, Evette; Kennedy, Peter J.; Central Clinical School: Medicine; Pharmacy; Concord Clinical School: Medicine; Concord Clinical School: Surgery; Pharmacy; PharmacyVancomycin pharmacokinetics in patients with severe burn injuries, Burns, vol.36, 4, 2010,pp 469-476
2014Voriconazole pharmacokinetics and exposure-response relationships: Assessing the links between exposure, efficacy and toxicityDolton, Michael; McLachlan, Andrew; Pharmacy; PharmacyVoriconazole pharmacokinetics and exposure-response relationships: Assessing the links between exposure, efficacy and toxicity, International Journal of Antimicrobial Agents, vol.44, 3, 2014,pp 183-193